A Pilot Trial of Patient Decision Aids for Implantable Cardioverter-Defibrillators (ICDs)

Sponsor
University of Colorado, Denver (Other)
Overall Status
Completed
CT.gov ID
NCT02026102
Collaborator
(none)
15
3
2
26
5
0.2

Study Details

Study Description

Brief Summary

The purpose of this study is to test the acceptability and feasibility of a "toolkit" of patient decision aids (PtDAs) for heart failure patients who are considering an ICD implant.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: ICD Decision Aid Toolkit
N/A

Detailed Description

Specific Aim 1: Examine acceptability and feasibility of a toolkit of patient decision aids (PtDAs) for patients with heart failure referred for primary prevention implantable cardioverter-defibrillators using a randomized control trial design across three diverse health care systems (Kaiser Colorado, The University of Colorado, and The Denver Veterans Hospital).

  1. Measure the acceptability of the decision aids

  2. Explore feasibility by measuring patient participation rates and adherence to the study protocol across all three sites.

  3. Conduct a preliminary assessment of outcomes by measuring changes in decision quality (knowledge and value concordance), quality of life, depressive symptoms, health status, and spiritual well-being.

Specific Aim 2: Determine the relative value of the various tools in the toolkit through in-depth interviews from study participants and providers at each intervention site

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
A Pilot Trial of Patient Decision Aids for Implantable Cardioverter-Defibrillators (ICDs)
Study Start Date :
Sep 1, 2014
Actual Primary Completion Date :
Aug 1, 2016
Actual Study Completion Date :
Nov 1, 2016

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Usual Care

Patients will receive no additional ICD specific information other than what is offered by the clinic consistent with usual care. The control group will be asked where they went for information in the follow-up interviews.

Experimental: ICD Decision Aid Toolkit

In the intervention arm, research assistants will provide the patients with the toolkit of decision aids. At that time, participants will have the option of using all of the decision aids or just some of the decision aids. Participants who do not have access to the internet, will be offered a DVD (digital video disc) version of the video and they will be asked if they would like to arrange a visit where they can review the website with the research assistant.

Behavioral: ICD Decision Aid Toolkit
Research assistants will provide patients with a toolkit of decision aids. Participants will have the option of using all of the decision aids or just some of the decision aids.

Outcome Measures

Primary Outcome Measures

  1. Measure the acceptability and feasibility of the decision aids [pre-ICD discussion - baseline]

    Acceptability-measure decision aid acceptability using modified version of decision aid acceptability developed by Barry et al. Feasibility-explore participation rates and adherence to study protocol; weekly team meetings to discuss recruitment strategies Knowledge: 21 item knowledge measure developed in-house Decision Conflict: validated 15-item decision conflict measure developed by O'Connor et al. Decision Regret: validated 5-item decision regret scale Decision choice: ultimate choice patient made about getting an ICD Decision participation: Prior to intervention, we measure patients' preferred role in decision making using the control preferences scale. After the decision, we measure the participants' actual role in decision making. Anxiety and Depression: Hospital Anxiety and Depression Scale (HADS). Chart Review Outcome: For those that had not yet had a procedure, we will review the charts at the end of study to determine if they received an ICD or not.

Secondary Outcome Measures

  1. Determine relative value of the four decision aids [3 months after baseline interview]

    Determine the relative value of the various tools in the toolkit through in-depth interviews from study participants and providers at each intervention site. We will ask participants the following questions: Have you made a decision about getting or not getting the ICD? What information did you use to make your decision? How are you feeling about your decision? What else would have been helpful in making your decision? (Intervention only) Did you use any of the decision aids you were given? If yes, please tell us how you used them? Did the decision aids make you feel better or worse about your decision? Did you like one of them better than the others? Is there any aspect that wasn't helpful? If no, please tell us why not? What would have been helpful? Do you have any advice on the best way to deliver these decision aids to future patients?

  2. Measure the acceptability and feasibility of the decision aids [within 4 weeks of meeting with electrophysiologist]

    Acceptability-measure decision aid acceptability using modified version of decision aid acceptability developed by Barry et al. Feasibility-explore participation rates and adherence to study protocol; weekly team meetings to discuss recruitment strategies Knowledge: 21 item knowledge measure developed in-house Decision Conflict: validated 15-item decision conflict measure developed by O'Connor et al. Decision Regret: validated 5-item decision regret scale Decision choice: ultimate choice patient made about getting an ICD Decision participation: Prior to intervention, we measure patients' preferred role in decision making using the control preferences scale. After the decision, we measure the participants' actual role in decision making. Anxiety and Depression: Hospital Anxiety and Depression Scale (HADS). Chart Review Outcome: For those that had not yet had a procedure, we will review the charts at the end of study to determine if they received an ICD or not.

  3. Measure the acceptability and feasibility of the decision aids [3 months after baseline interview]

    Acceptability-measure decision aid acceptability using modified version of decision aid acceptability developed by Barry et al. Feasibility-explore participation rates and adherence to study protocol; weekly team meetings to discuss recruitment strategies Knowledge: 21 item knowledge measure developed in-house Decision Conflict: validated 15-item decision conflict measure developed by O'Connor et al. Decision Regret: validated 5-item decision regret scale Decision choice: ultimate choice patient made about getting an ICD Decision participation: Prior to intervention, we measure patients' preferred role in decision making using the control preferences scale. After the decision, we measure the participants' actual role in decision making. Anxiety and Depression: Hospital Anxiety and Depression Scale (HADS). Chart Review Outcome: For those that had not yet had a procedure, we will review the charts at the end of study to determine if they received an ICD or not.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • systolic heart failure (defined as an ejection fraction less than 35%)

  • have been referred for a primary prevention ICD

  • Note: Patients referred for an ICD with cardiac resynchronization therapy are NOT excluded.

Exclusion Criteria:
  • Already have an ICD

  • Non-English speaking (as the tools we have developed are only available in English currently)

  • Other ICD indications (e.g. secondary prevention, hypertrophic obstructive cardiomyopathy)

  • Cognitive Impairment defined only as people with an inability to consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Colorado Hospital (UCH) Aurora Colorado United States 80045
2 Kaiser Permanente of Colorado Denver Colorado United States 80218
3 Denver VA Medical Center Denver Colorado United States 80220

Sponsors and Collaborators

  • University of Colorado, Denver

Investigators

  • Principal Investigator: Daniel D Matlock, MD, MPH, University of Colorado, Denver

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT02026102
Other Study ID Numbers:
  • 13-3152
  • 121483
First Posted:
Jan 1, 2014
Last Update Posted:
Oct 31, 2019
Last Verified:
Oct 1, 2019

Study Results

No Results Posted as of Oct 31, 2019